On July 25, The European Medicines Agency (EMA)’s advisory committee recommended Gilead Sciences’ Lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and …
Tag:
HIV
-
-
Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for …
-
The UN warns that funding cuts will have catastrophic consequences for the fight against the disease. The United Nations AIDS agency is warning that …
-
Rare blood types, twice-a-year HIV prevention, and rising maternal health risks | Health Wrap by The Hindu | Video Credit: The Hindu In this …
